
GenoDeep offers a blood-based cancer screening that detects multiple cancers with a simple test. It uses combined assays of altered cfDNA and protein biomarkers and a deep learning algorithm to identify cancer fingerprints. The system targets eight cancer types and yields high sensitivity and specificity, with results presented in a Bayesian report. It is a B2B health tech solution serving laboratories and clinics, designed to integrate into existing diagnostic workflows.

GenoDeep offers a blood-based cancer screening that detects multiple cancers with a simple test. It uses combined assays of altered cfDNA and protein biomarkers and a deep learning algorithm to identify cancer fingerprints. The system targets eight cancer types and yields high sensitivity and specificity, with results presented in a Bayesian report. It is a B2B health tech solution serving laboratories and clinics, designed to integrate into existing diagnostic workflows.